PTN Stock Analysis: Buy, Sell, or Hold?
$13.50
-0.40 (-2.88%)
▼
5d:
-8.04%
30d:
-32.63%
90d:
-36.41%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When PTN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PTN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PTN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PTN is currently trading at $13.50, which is considered oversold relative to its 30-day fair value range of $14.18 to $19.74.
Technical Outlook: Technically, PTN is showing sideways momentum. Immediate support is located at $13.09, while resistance sits at $15.01.
Market Sentiment: PTN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $53.50 (+296.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PTN is showing sideways momentum. Immediate support is located at $13.09, while resistance sits at $15.01.
Market Sentiment: PTN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $53.50 (+296.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.18 -
$19.74
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 296.3% below Wall St target ($53.50)
- CAUTION: 5-day price weakness (-8.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$14.18 -
$19.74
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$13.09
Resistance Level
$15.01
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.56
Wall Street Target
$53.50
(+296.3%)
Revenue Growth (YoY)
-80.1%
Profit Margin
-48.5%
Share & Embed Analysis
Last updated: June 04, 2026 1:58 AM ET
Data refreshes hourly during market hours. Next update: 2:58 AM
Data refreshes hourly during market hours. Next update: 2:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTN showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 55 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 56 HOLD |